EGFR and neoplasm: Propensity scores(PS) were calculated using a Logistic regression model that included variables such as age, tumor location, T stage, N stage, M stage, distant metastasis (bone, brain, liver, lung), pathological type, EGFR mutation status, surgical treatment, chemotherapy, radiotherapy, AAT therapy, EGFR-TKI treatment, and ICIs treatment.